nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Donepezil—Alzheimer's disease	0.169	1	CbGbCtD
Treprostinil—PTGIR—blood vessel—Alzheimer's disease	0.0157	0.128	CbGeAlD
Treprostinil—P2RY12—forebrain—Alzheimer's disease	0.013	0.106	CbGeAlD
Treprostinil—PPARD—forebrain—Alzheimer's disease	0.0108	0.0881	CbGeAlD
Treprostinil—PPARD—telencephalon—Alzheimer's disease	0.00991	0.081	CbGeAlD
Treprostinil—PTGIR—forebrain—Alzheimer's disease	0.00827	0.0676	CbGeAlD
Treprostinil—PTGIR—telencephalon—Alzheimer's disease	0.00761	0.0622	CbGeAlD
Treprostinil—P2RY12—nervous system—Alzheimer's disease	0.00704	0.0575	CbGeAlD
Treprostinil—P2RY12—central nervous system—Alzheimer's disease	0.00678	0.0554	CbGeAlD
Treprostinil—PPARD—nervous system—Alzheimer's disease	0.00585	0.0478	CbGeAlD
Treprostinil—PPARD—central nervous system—Alzheimer's disease	0.00563	0.046	CbGeAlD
Treprostinil—PPARD—cerebellum—Alzheimer's disease	0.0055	0.045	CbGeAlD
Treprostinil—P2RY12—brain—Alzheimer's disease	0.00538	0.044	CbGeAlD
Treprostinil—PTGIR—nervous system—Alzheimer's disease	0.00449	0.0367	CbGeAlD
Treprostinil—PPARD—brain—Alzheimer's disease	0.00447	0.0365	CbGeAlD
Treprostinil—PTGIR—central nervous system—Alzheimer's disease	0.00432	0.0353	CbGeAlD
Treprostinil—PTGIR—cerebellum—Alzheimer's disease	0.00423	0.0345	CbGeAlD
Treprostinil—PTGIR—brain—Alzheimer's disease	0.00343	0.0281	CbGeAlD
Treprostinil—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00287	0.00582	CcSEcCtD
Treprostinil—Melaena—Memantine—Alzheimer's disease	0.00286	0.00581	CcSEcCtD
Treprostinil—Dehydration—Galantamine—Alzheimer's disease	0.00281	0.0057	CcSEcCtD
Treprostinil—Sepsis—Donepezil—Alzheimer's disease	0.0028	0.00568	CcSEcCtD
Treprostinil—Melaena—Rivastigmine—Alzheimer's disease	0.0028	0.00568	CcSEcCtD
Treprostinil—Hypokalaemia—Galantamine—Alzheimer's disease	0.00275	0.00558	CcSEcCtD
Treprostinil—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.00263	0.00534	CcSEcCtD
Treprostinil—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00258	0.00524	CcSEcCtD
Treprostinil—Sepsis—Memantine—Alzheimer's disease	0.00254	0.00516	CcSEcCtD
Treprostinil—Bronchitis—Galantamine—Alzheimer's disease	0.00251	0.0051	CcSEcCtD
Treprostinil—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00251	0.00508	CcSEcCtD
Treprostinil—Sepsis—Rivastigmine—Alzheimer's disease	0.00249	0.00505	CcSEcCtD
Treprostinil—Thrombophlebitis—Memantine—Alzheimer's disease	0.00246	0.00498	CcSEcCtD
Treprostinil—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00241	0.00488	CcSEcCtD
Treprostinil—Cardiac failure—Donepezil—Alzheimer's disease	0.0024	0.00487	CcSEcCtD
Treprostinil—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00235	0.00476	CcSEcCtD
Treprostinil—Pneumonia—Galantamine—Alzheimer's disease	0.00234	0.00475	CcSEcCtD
Treprostinil—Depression—Galantamine—Alzheimer's disease	0.00232	0.00471	CcSEcCtD
Treprostinil—Urinary tract infection—Galantamine—Alzheimer's disease	0.00227	0.00459	CcSEcCtD
Treprostinil—Haematuria—Galantamine—Alzheimer's disease	0.00222	0.00451	CcSEcCtD
Treprostinil—Epistaxis—Galantamine—Alzheimer's disease	0.0022	0.00446	CcSEcCtD
Treprostinil—Cardiac failure—Memantine—Alzheimer's disease	0.00218	0.00442	CcSEcCtD
Treprostinil—Dehydration—Donepezil—Alzheimer's disease	0.00218	0.00442	CcSEcCtD
Treprostinil—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00213	0.00433	CcSEcCtD
Treprostinil—Hypokalaemia—Donepezil—Alzheimer's disease	0.00213	0.00433	CcSEcCtD
Treprostinil—Bradycardia—Galantamine—Alzheimer's disease	0.00213	0.00432	CcSEcCtD
Treprostinil—Pain in extremity—Memantine—Alzheimer's disease	0.00213	0.00431	CcSEcCtD
Treprostinil—Haemoglobin—Galantamine—Alzheimer's disease	0.0021	0.00426	CcSEcCtD
Treprostinil—Rhinitis—Galantamine—Alzheimer's disease	0.0021	0.00425	CcSEcCtD
Treprostinil—Haemorrhage—Galantamine—Alzheimer's disease	0.00209	0.00424	CcSEcCtD
Treprostinil—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00208	0.00422	CcSEcCtD
Treprostinil—Oedema peripheral—Galantamine—Alzheimer's disease	0.00206	0.00418	CcSEcCtD
Treprostinil—Influenza—Donepezil—Alzheimer's disease	0.00203	0.00411	CcSEcCtD
Treprostinil—Dehydration—Memantine—Alzheimer's disease	0.00198	0.00401	CcSEcCtD
Treprostinil—Bronchitis—Donepezil—Alzheimer's disease	0.00195	0.00395	CcSEcCtD
Treprostinil—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00194	0.00394	CcSEcCtD
Treprostinil—Flushing—Galantamine—Alzheimer's disease	0.00194	0.00394	CcSEcCtD
Treprostinil—Hypokalaemia—Memantine—Alzheimer's disease	0.00194	0.00393	CcSEcCtD
Treprostinil—Dehydration—Rivastigmine—Alzheimer's disease	0.00194	0.00393	CcSEcCtD
Treprostinil—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00189	0.00384	CcSEcCtD
Treprostinil—Influenza—Memantine—Alzheimer's disease	0.00184	0.00373	CcSEcCtD
Treprostinil—Pneumonia—Donepezil—Alzheimer's disease	0.00182	0.00368	CcSEcCtD
Treprostinil—Depression—Donepezil—Alzheimer's disease	0.0018	0.00365	CcSEcCtD
Treprostinil—Tension—Galantamine—Alzheimer's disease	0.00179	0.00362	CcSEcCtD
Treprostinil—Nervousness—Galantamine—Alzheimer's disease	0.00177	0.00359	CcSEcCtD
Treprostinil—Bronchitis—Memantine—Alzheimer's disease	0.00177	0.00359	CcSEcCtD
Treprostinil—Back pain—Galantamine—Alzheimer's disease	0.00176	0.00357	CcSEcCtD
Treprostinil—Urinary tract infection—Donepezil—Alzheimer's disease	0.00176	0.00356	CcSEcCtD
Treprostinil—Muscle spasms—Galantamine—Alzheimer's disease	0.00175	0.00355	CcSEcCtD
Treprostinil—Bronchitis—Rivastigmine—Alzheimer's disease	0.00173	0.00351	CcSEcCtD
Treprostinil—Haematuria—Donepezil—Alzheimer's disease	0.00172	0.00349	CcSEcCtD
Treprostinil—Epistaxis—Donepezil—Alzheimer's disease	0.0017	0.00345	CcSEcCtD
Treprostinil—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00169	0.00343	CcSEcCtD
Treprostinil—Anaemia—Galantamine—Alzheimer's disease	0.00168	0.00341	CcSEcCtD
Treprostinil—Bradycardia—Donepezil—Alzheimer's disease	0.00165	0.00335	CcSEcCtD
Treprostinil—Pneumonia—Memantine—Alzheimer's disease	0.00165	0.00334	CcSEcCtD
Treprostinil—Malaise—Galantamine—Alzheimer's disease	0.00164	0.00333	CcSEcCtD
Treprostinil—Depression—Memantine—Alzheimer's disease	0.00164	0.00332	CcSEcCtD
Treprostinil—Syncope—Galantamine—Alzheimer's disease	0.00163	0.00331	CcSEcCtD
Treprostinil—Haemoglobin—Donepezil—Alzheimer's disease	0.00163	0.0033	CcSEcCtD
Treprostinil—Rhinitis—Donepezil—Alzheimer's disease	0.00163	0.0033	CcSEcCtD
Treprostinil—Haemorrhage—Donepezil—Alzheimer's disease	0.00162	0.00329	CcSEcCtD
Treprostinil—Pneumonia—Rivastigmine—Alzheimer's disease	0.00161	0.00327	CcSEcCtD
Treprostinil—Palpitations—Galantamine—Alzheimer's disease	0.00161	0.00326	CcSEcCtD
Treprostinil—Pharyngitis—Donepezil—Alzheimer's disease	0.00161	0.00326	CcSEcCtD
Treprostinil—Loss of consciousness—Galantamine—Alzheimer's disease	0.0016	0.00325	CcSEcCtD
Treprostinil—Depression—Rivastigmine—Alzheimer's disease	0.0016	0.00324	CcSEcCtD
Treprostinil—Oedema peripheral—Donepezil—Alzheimer's disease	0.0016	0.00324	CcSEcCtD
Treprostinil—Urinary tract infection—Memantine—Alzheimer's disease	0.00159	0.00323	CcSEcCtD
Treprostinil—Cough—Galantamine—Alzheimer's disease	0.00159	0.00322	CcSEcCtD
Treprostinil—Haematuria—Memantine—Alzheimer's disease	0.00156	0.00317	CcSEcCtD
Treprostinil—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00156	0.00316	CcSEcCtD
Treprostinil—Chest pain—Galantamine—Alzheimer's disease	0.00155	0.00314	CcSEcCtD
Treprostinil—Arthralgia—Galantamine—Alzheimer's disease	0.00155	0.00314	CcSEcCtD
Treprostinil—Myalgia—Galantamine—Alzheimer's disease	0.00155	0.00314	CcSEcCtD
Treprostinil—Epistaxis—Memantine—Alzheimer's disease	0.00155	0.00314	CcSEcCtD
Treprostinil—Anxiety—Galantamine—Alzheimer's disease	0.00155	0.00313	CcSEcCtD
Treprostinil—Sinusitis—Memantine—Alzheimer's disease	0.00154	0.00312	CcSEcCtD
Treprostinil—Discomfort—Galantamine—Alzheimer's disease	0.00153	0.00311	CcSEcCtD
Treprostinil—Haematuria—Rivastigmine—Alzheimer's disease	0.00153	0.0031	CcSEcCtD
Treprostinil—Epistaxis—Rivastigmine—Alzheimer's disease	0.00151	0.00307	CcSEcCtD
Treprostinil—Sinusitis—Rivastigmine—Alzheimer's disease	0.00151	0.00305	CcSEcCtD
Treprostinil—Bradycardia—Memantine—Alzheimer's disease	0.0015	0.00304	CcSEcCtD
Treprostinil—Haemoglobin—Memantine—Alzheimer's disease	0.00148	0.003	CcSEcCtD
Treprostinil—Rhinitis—Memantine—Alzheimer's disease	0.00148	0.00299	CcSEcCtD
Treprostinil—Haemorrhage—Memantine—Alzheimer's disease	0.00147	0.00299	CcSEcCtD
Treprostinil—Bradycardia—Rivastigmine—Alzheimer's disease	0.00147	0.00297	CcSEcCtD
Treprostinil—Shock—Galantamine—Alzheimer's disease	0.00146	0.00297	CcSEcCtD
Treprostinil—Pharyngitis—Memantine—Alzheimer's disease	0.00146	0.00296	CcSEcCtD
Treprostinil—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00146	0.00295	CcSEcCtD
Treprostinil—Tachycardia—Galantamine—Alzheimer's disease	0.00145	0.00294	CcSEcCtD
Treprostinil—Oedema peripheral—Memantine—Alzheimer's disease	0.00145	0.00294	CcSEcCtD
Treprostinil—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00145	0.00294	CcSEcCtD
Treprostinil—Rhinitis—Rivastigmine—Alzheimer's disease	0.00144	0.00293	CcSEcCtD
Treprostinil—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00144	0.00292	CcSEcCtD
Treprostinil—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00143	0.0029	CcSEcCtD
Treprostinil—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00142	0.00288	CcSEcCtD
Treprostinil—Anorexia—Galantamine—Alzheimer's disease	0.00142	0.00287	CcSEcCtD
Treprostinil—Erythema—Donepezil—Alzheimer's disease	0.00141	0.00286	CcSEcCtD
Treprostinil—Hypotension—Galantamine—Alzheimer's disease	0.00139	0.00282	CcSEcCtD
Treprostinil—Tension—Donepezil—Alzheimer's disease	0.00139	0.00281	CcSEcCtD
Treprostinil—Nervousness—Donepezil—Alzheimer's disease	0.00137	0.00278	CcSEcCtD
Treprostinil—Flushing—Memantine—Alzheimer's disease	0.00137	0.00277	CcSEcCtD
Treprostinil—Back pain—Donepezil—Alzheimer's disease	0.00137	0.00277	CcSEcCtD
Treprostinil—Muscle spasms—Donepezil—Alzheimer's disease	0.00136	0.00275	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00135	0.00275	CcSEcCtD
Treprostinil—Insomnia—Galantamine—Alzheimer's disease	0.00134	0.00273	CcSEcCtD
Treprostinil—Flushing—Rivastigmine—Alzheimer's disease	0.00134	0.00271	CcSEcCtD
Treprostinil—Paraesthesia—Galantamine—Alzheimer's disease	0.00133	0.00271	CcSEcCtD
Treprostinil—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00131	0.00266	CcSEcCtD
Treprostinil—Dyspepsia—Galantamine—Alzheimer's disease	0.00131	0.00265	CcSEcCtD
Treprostinil—Anaemia—Donepezil—Alzheimer's disease	0.0013	0.00265	CcSEcCtD
Treprostinil—Decreased appetite—Galantamine—Alzheimer's disease	0.00129	0.00262	CcSEcCtD
Treprostinil—Fatigue—Galantamine—Alzheimer's disease	0.00128	0.0026	CcSEcCtD
Treprostinil—Malaise—Donepezil—Alzheimer's disease	0.00127	0.00258	CcSEcCtD
Treprostinil—Syncope—Donepezil—Alzheimer's disease	0.00127	0.00257	CcSEcCtD
Treprostinil—Tension—Memantine—Alzheimer's disease	0.00126	0.00255	CcSEcCtD
Treprostinil—Erythema—Rivastigmine—Alzheimer's disease	0.00125	0.00254	CcSEcCtD
Treprostinil—Nervousness—Memantine—Alzheimer's disease	0.00124	0.00252	CcSEcCtD
Treprostinil—Loss of consciousness—Donepezil—Alzheimer's disease	0.00124	0.00252	CcSEcCtD
Treprostinil—Back pain—Memantine—Alzheimer's disease	0.00124	0.00251	CcSEcCtD
Treprostinil—Cough—Donepezil—Alzheimer's disease	0.00123	0.0025	CcSEcCtD
Treprostinil—Tension—Rivastigmine—Alzheimer's disease	0.00123	0.00249	CcSEcCtD
Treprostinil—Feeling abnormal—Galantamine—Alzheimer's disease	0.00122	0.00248	CcSEcCtD
Treprostinil—Nervousness—Rivastigmine—Alzheimer's disease	0.00122	0.00247	CcSEcCtD
Treprostinil—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00122	0.00246	CcSEcCtD
Treprostinil—Back pain—Rivastigmine—Alzheimer's disease	0.00121	0.00246	CcSEcCtD
Treprostinil—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00121	0.00244	CcSEcCtD
Treprostinil—Chest pain—Donepezil—Alzheimer's disease	0.0012	0.00244	CcSEcCtD
Treprostinil—Myalgia—Donepezil—Alzheimer's disease	0.0012	0.00244	CcSEcCtD
Treprostinil—Arthralgia—Donepezil—Alzheimer's disease	0.0012	0.00244	CcSEcCtD
Treprostinil—Anxiety—Donepezil—Alzheimer's disease	0.0012	0.00243	CcSEcCtD
Treprostinil—Ill-defined disorder—Memantine—Alzheimer's disease	0.00119	0.00241	CcSEcCtD
Treprostinil—Discomfort—Donepezil—Alzheimer's disease	0.00119	0.00241	CcSEcCtD
Treprostinil—Anaemia—Memantine—Alzheimer's disease	0.00118	0.0024	CcSEcCtD
Treprostinil—Body temperature increased—Galantamine—Alzheimer's disease	0.00118	0.00238	CcSEcCtD
Treprostinil—Abdominal pain—Galantamine—Alzheimer's disease	0.00118	0.00238	CcSEcCtD
Treprostinil—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00236	CcSEcCtD
Treprostinil—Anaemia—Rivastigmine—Alzheimer's disease	0.00116	0.00235	CcSEcCtD
Treprostinil—Malaise—Memantine—Alzheimer's disease	0.00116	0.00234	CcSEcCtD
Treprostinil—Oedema—Donepezil—Alzheimer's disease	0.00115	0.00234	CcSEcCtD
Treprostinil—Syncope—Memantine—Alzheimer's disease	0.00115	0.00233	CcSEcCtD
Treprostinil—Infection—Donepezil—Alzheimer's disease	0.00114	0.00232	CcSEcCtD
Treprostinil—Shock—Donepezil—Alzheimer's disease	0.00113	0.0023	CcSEcCtD
Treprostinil—Palpitations—Memantine—Alzheimer's disease	0.00113	0.0023	CcSEcCtD
Treprostinil—Malaise—Rivastigmine—Alzheimer's disease	0.00113	0.00229	CcSEcCtD
Treprostinil—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00113	0.00229	CcSEcCtD
Treprostinil—Loss of consciousness—Memantine—Alzheimer's disease	0.00113	0.00228	CcSEcCtD
Treprostinil—Syncope—Rivastigmine—Alzheimer's disease	0.00112	0.00228	CcSEcCtD
Treprostinil—Cough—Memantine—Alzheimer's disease	0.00112	0.00227	CcSEcCtD
Treprostinil—Palpitations—Rivastigmine—Alzheimer's disease	0.00111	0.00225	CcSEcCtD
Treprostinil—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0011	0.00223	CcSEcCtD
Treprostinil—Anorexia—Donepezil—Alzheimer's disease	0.0011	0.00223	CcSEcCtD
Treprostinil—Cough—Rivastigmine—Alzheimer's disease	0.00109	0.00222	CcSEcCtD
Treprostinil—Arthralgia—Memantine—Alzheimer's disease	0.00109	0.00221	CcSEcCtD
Treprostinil—Chest pain—Memantine—Alzheimer's disease	0.00109	0.00221	CcSEcCtD
Treprostinil—Myalgia—Memantine—Alzheimer's disease	0.00109	0.00221	CcSEcCtD
Treprostinil—Anxiety—Memantine—Alzheimer's disease	0.00109	0.0022	CcSEcCtD
Treprostinil—Discomfort—Memantine—Alzheimer's disease	0.00108	0.00219	CcSEcCtD
Treprostinil—Hypotension—Donepezil—Alzheimer's disease	0.00108	0.00218	CcSEcCtD
Treprostinil—Myalgia—Rivastigmine—Alzheimer's disease	0.00107	0.00216	CcSEcCtD
Treprostinil—Arthralgia—Rivastigmine—Alzheimer's disease	0.00107	0.00216	CcSEcCtD
Treprostinil—Chest pain—Rivastigmine—Alzheimer's disease	0.00107	0.00216	CcSEcCtD
Treprostinil—Asthenia—Galantamine—Alzheimer's disease	0.00107	0.00216	CcSEcCtD
Treprostinil—Anxiety—Rivastigmine—Alzheimer's disease	0.00106	0.00216	CcSEcCtD
Treprostinil—Discomfort—Rivastigmine—Alzheimer's disease	0.00105	0.00214	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00105	0.00213	CcSEcCtD
Treprostinil—Oedema—Memantine—Alzheimer's disease	0.00105	0.00212	CcSEcCtD
Treprostinil—Insomnia—Donepezil—Alzheimer's disease	0.00104	0.00211	CcSEcCtD
Treprostinil—Infection—Memantine—Alzheimer's disease	0.00104	0.00211	CcSEcCtD
Treprostinil—Paraesthesia—Donepezil—Alzheimer's disease	0.00103	0.0021	CcSEcCtD
Treprostinil—Shock—Memantine—Alzheimer's disease	0.00103	0.00209	CcSEcCtD
Treprostinil—Dyspnoea—Donepezil—Alzheimer's disease	0.00103	0.00208	CcSEcCtD
Treprostinil—Thrombocytopenia—Memantine—Alzheimer's disease	0.00102	0.00208	CcSEcCtD
Treprostinil—Oedema—Rivastigmine—Alzheimer's disease	0.00102	0.00207	CcSEcCtD
Treprostinil—Tachycardia—Memantine—Alzheimer's disease	0.00102	0.00207	CcSEcCtD
Treprostinil—Diarrhoea—Galantamine—Alzheimer's disease	0.00102	0.00206	CcSEcCtD
Treprostinil—Infection—Rivastigmine—Alzheimer's disease	0.00102	0.00206	CcSEcCtD
Treprostinil—Dyspepsia—Donepezil—Alzheimer's disease	0.00101	0.00206	CcSEcCtD
Treprostinil—Shock—Rivastigmine—Alzheimer's disease	0.00101	0.00204	CcSEcCtD
Treprostinil—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.001	0.00203	CcSEcCtD
Treprostinil—Decreased appetite—Donepezil—Alzheimer's disease	0.001	0.00203	CcSEcCtD
Treprostinil—Tachycardia—Rivastigmine—Alzheimer's disease	0.000999	0.00202	CcSEcCtD
Treprostinil—Anorexia—Memantine—Alzheimer's disease	0.000997	0.00202	CcSEcCtD
Treprostinil—Fatigue—Donepezil—Alzheimer's disease	0.000993	0.00201	CcSEcCtD
Treprostinil—Pain—Donepezil—Alzheimer's disease	0.000985	0.002	CcSEcCtD
Treprostinil—Dizziness—Galantamine—Alzheimer's disease	0.000983	0.00199	CcSEcCtD
Treprostinil—Hypotension—Memantine—Alzheimer's disease	0.000977	0.00198	CcSEcCtD
Treprostinil—Anorexia—Rivastigmine—Alzheimer's disease	0.000975	0.00198	CcSEcCtD
Treprostinil—Hypotension—Rivastigmine—Alzheimer's disease	0.000956	0.00194	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000953	0.00193	CcSEcCtD
Treprostinil—Feeling abnormal—Donepezil—Alzheimer's disease	0.000949	0.00192	CcSEcCtD
Treprostinil—Insomnia—Memantine—Alzheimer's disease	0.000946	0.00192	CcSEcCtD
Treprostinil—Vomiting—Galantamine—Alzheimer's disease	0.000945	0.00192	CcSEcCtD
Treprostinil—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000942	0.00191	CcSEcCtD
Treprostinil—Paraesthesia—Memantine—Alzheimer's disease	0.000939	0.0019	CcSEcCtD
Treprostinil—Rash—Galantamine—Alzheimer's disease	0.000937	0.0019	CcSEcCtD
Treprostinil—Dermatitis—Galantamine—Alzheimer's disease	0.000936	0.0019	CcSEcCtD
Treprostinil—Dyspnoea—Memantine—Alzheimer's disease	0.000933	0.00189	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000932	0.00189	CcSEcCtD
Treprostinil—Headache—Galantamine—Alzheimer's disease	0.000931	0.00189	CcSEcCtD
Treprostinil—Insomnia—Rivastigmine—Alzheimer's disease	0.000925	0.00188	CcSEcCtD
Treprostinil—Dyspepsia—Memantine—Alzheimer's disease	0.000921	0.00187	CcSEcCtD
Treprostinil—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000919	0.00186	CcSEcCtD
Treprostinil—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000912	0.00185	CcSEcCtD
Treprostinil—Abdominal pain—Donepezil—Alzheimer's disease	0.000911	0.00185	CcSEcCtD
Treprostinil—Body temperature increased—Donepezil—Alzheimer's disease	0.000911	0.00185	CcSEcCtD
Treprostinil—Decreased appetite—Memantine—Alzheimer's disease	0.000909	0.00184	CcSEcCtD
Treprostinil—Fatigue—Memantine—Alzheimer's disease	0.000902	0.00183	CcSEcCtD
Treprostinil—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000901	0.00183	CcSEcCtD
Treprostinil—Pain—Memantine—Alzheimer's disease	0.000894	0.00181	CcSEcCtD
Treprostinil—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00089	0.0018	CcSEcCtD
Treprostinil—Nausea—Galantamine—Alzheimer's disease	0.000883	0.00179	CcSEcCtD
Treprostinil—Fatigue—Rivastigmine—Alzheimer's disease	0.000882	0.00179	CcSEcCtD
Treprostinil—Pain—Rivastigmine—Alzheimer's disease	0.000875	0.00177	CcSEcCtD
Treprostinil—Feeling abnormal—Memantine—Alzheimer's disease	0.000862	0.00175	CcSEcCtD
Treprostinil—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000855	0.00173	CcSEcCtD
Treprostinil—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000843	0.00171	CcSEcCtD
Treprostinil—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000837	0.0017	CcSEcCtD
Treprostinil—Abdominal pain—Memantine—Alzheimer's disease	0.000827	0.00168	CcSEcCtD
Treprostinil—Body temperature increased—Memantine—Alzheimer's disease	0.000827	0.00168	CcSEcCtD
Treprostinil—Asthenia—Donepezil—Alzheimer's disease	0.000827	0.00168	CcSEcCtD
Treprostinil—Pruritus—Donepezil—Alzheimer's disease	0.000815	0.00165	CcSEcCtD
Treprostinil—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000809	0.00164	CcSEcCtD
Treprostinil—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000809	0.00164	CcSEcCtD
Treprostinil—Diarrhoea—Donepezil—Alzheimer's disease	0.000788	0.0016	CcSEcCtD
Treprostinil—Dizziness—Donepezil—Alzheimer's disease	0.000762	0.00154	CcSEcCtD
Treprostinil—Asthenia—Memantine—Alzheimer's disease	0.00075	0.00152	CcSEcCtD
Treprostinil—Pruritus—Memantine—Alzheimer's disease	0.00074	0.0015	CcSEcCtD
Treprostinil—Asthenia—Rivastigmine—Alzheimer's disease	0.000734	0.00149	CcSEcCtD
Treprostinil—Vomiting—Donepezil—Alzheimer's disease	0.000732	0.00149	CcSEcCtD
Treprostinil—Rash—Donepezil—Alzheimer's disease	0.000726	0.00147	CcSEcCtD
Treprostinil—Dermatitis—Donepezil—Alzheimer's disease	0.000726	0.00147	CcSEcCtD
Treprostinil—Pruritus—Rivastigmine—Alzheimer's disease	0.000724	0.00147	CcSEcCtD
Treprostinil—Headache—Donepezil—Alzheimer's disease	0.000722	0.00146	CcSEcCtD
Treprostinil—Diarrhoea—Memantine—Alzheimer's disease	0.000716	0.00145	CcSEcCtD
Treprostinil—Diarrhoea—Rivastigmine—Alzheimer's disease	0.0007	0.00142	CcSEcCtD
Treprostinil—Dizziness—Memantine—Alzheimer's disease	0.000692	0.0014	CcSEcCtD
Treprostinil—Nausea—Donepezil—Alzheimer's disease	0.000684	0.00139	CcSEcCtD
Treprostinil—Dizziness—Rivastigmine—Alzheimer's disease	0.000677	0.00137	CcSEcCtD
Treprostinil—Vomiting—Memantine—Alzheimer's disease	0.000665	0.00135	CcSEcCtD
Treprostinil—Rash—Memantine—Alzheimer's disease	0.000659	0.00134	CcSEcCtD
Treprostinil—Dermatitis—Memantine—Alzheimer's disease	0.000659	0.00134	CcSEcCtD
Treprostinil—Headache—Memantine—Alzheimer's disease	0.000655	0.00133	CcSEcCtD
Treprostinil—Vomiting—Rivastigmine—Alzheimer's disease	0.000651	0.00132	CcSEcCtD
Treprostinil—Rash—Rivastigmine—Alzheimer's disease	0.000645	0.00131	CcSEcCtD
Treprostinil—Dermatitis—Rivastigmine—Alzheimer's disease	0.000645	0.00131	CcSEcCtD
Treprostinil—Headache—Rivastigmine—Alzheimer's disease	0.000641	0.0013	CcSEcCtD
Treprostinil—Nausea—Memantine—Alzheimer's disease	0.000621	0.00126	CcSEcCtD
Treprostinil—Nausea—Rivastigmine—Alzheimer's disease	0.000608	0.00123	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CDK5—Alzheimer's disease	0.000218	0.00101	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—F2—Alzheimer's disease	0.000218	0.00101	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—APP—Alzheimer's disease	0.000217	0.00101	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MAOB—Alzheimer's disease	0.000217	0.00101	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	0.000215	0.001	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—APP—Alzheimer's disease	0.000214	0.000994	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000214	0.000993	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NPS—Alzheimer's disease	0.000212	0.000984	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—F2—Alzheimer's disease	0.000211	0.000982	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL2—Alzheimer's disease	0.000211	0.000979	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000211	0.000979	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR6—Alzheimer's disease	0.00021	0.000974	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PLAU—Alzheimer's disease	0.000209	0.000972	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS2—Alzheimer's disease	0.000209	0.000971	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GAPDH—Alzheimer's disease	0.000209	0.000969	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CALM1—Alzheimer's disease	0.000207	0.000962	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSENEN—Alzheimer's disease	0.000207	0.000961	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000206	0.000958	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000204	0.00095	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CAV1—Alzheimer's disease	0.000204	0.00095	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000204	0.000949	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APH1A—Alzheimer's disease	0.000204	0.000947	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—SST—Alzheimer's disease	0.000202	0.000938	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GAB2—Alzheimer's disease	0.000202	0.000938	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000202	0.000938	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—A2M—Alzheimer's disease	0.000201	0.000936	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000199	0.000924	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NCSTN—Alzheimer's disease	0.000198	0.000923	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—APP—Alzheimer's disease	0.000197	0.000914	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—F2—Alzheimer's disease	0.000195	0.000904	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL2—Alzheimer's disease	0.000194	0.000901	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LRP1—Alzheimer's disease	0.000194	0.0009	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000193	0.000897	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS2—Alzheimer's disease	0.000192	0.000893	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSENEN—Alzheimer's disease	0.00019	0.000884	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000189	0.00088	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GAL—Alzheimer's disease	0.000189	0.000879	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GFAP—Alzheimer's disease	0.000189	0.000879	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APH1A—Alzheimer's disease	0.000188	0.000872	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000187	0.000868	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000186	0.000863	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IGF1—Alzheimer's disease	0.000185	0.000861	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NCSTN—Alzheimer's disease	0.000183	0.000849	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.00018	0.000835	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LRP1—Alzheimer's disease	0.000178	0.000828	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000178	0.000825	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ACHE—Alzheimer's disease	0.000175	0.000814	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GAL—Alzheimer's disease	0.000174	0.000809	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GFAP—Alzheimer's disease	0.000174	0.000809	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—INPP5D—Alzheimer's disease	0.000173	0.000805	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IGF1—Alzheimer's disease	0.00017	0.000792	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NOS3—Alzheimer's disease	0.000168	0.00078	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—A2M—Alzheimer's disease	0.000167	0.000775	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000164	0.000764	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS1—Alzheimer's disease	0.000164	0.000763	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ENO1—Alzheimer's disease	0.000164	0.000763	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000164	0.000762	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSEN2—Alzheimer's disease	0.000161	0.00075	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP2D6—Alzheimer's disease	0.000161	0.000748	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000156	0.000724	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NOS3—Alzheimer's disease	0.000155	0.000718	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—A2M—Alzheimer's disease	0.000153	0.000713	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—BCHE—Alzheimer's disease	0.000153	0.000709	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000152	0.000708	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000151	0.000703	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	0.00015	0.000696	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000149	0.000693	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NPY—Alzheimer's disease	0.000149	0.00069	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000149	0.00069	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IAPP—Alzheimer's disease	0.000148	0.000686	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PLCB1—Alzheimer's disease	0.000144	0.000669	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CRH—Alzheimer's disease	0.000143	0.000666	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000143	0.000666	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR5—Alzheimer's disease	0.000141	0.000657	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000141	0.000657	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.00014	0.000652	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCA1—Alzheimer's disease	0.00014	0.000649	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000138	0.000643	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000137	0.000638	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NPY—Alzheimer's disease	0.000137	0.000635	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IAPP—Alzheimer's disease	0.000136	0.000631	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NPS—Alzheimer's disease	0.000136	0.000631	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000135	0.000628	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—F2—Alzheimer's disease	0.000134	0.000621	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTK2B—Alzheimer's disease	0.000133	0.000619	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CRH—Alzheimer's disease	0.000132	0.000613	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR5—Alzheimer's disease	0.00013	0.000605	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SST—Alzheimer's disease	0.00013	0.000602	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GAB2—Alzheimer's disease	0.00013	0.000602	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NTRK2—Alzheimer's disease	0.00013	0.000602	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CALM1—Alzheimer's disease	0.000129	0.0006	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GSK3A—Alzheimer's disease	0.000128	0.000597	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000127	0.000592	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APP—Alzheimer's disease	0.000126	0.000587	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NPS—Alzheimer's disease	0.000125	0.000581	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000124	0.000578	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—F2—Alzheimer's disease	0.000123	0.000571	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTK2B—Alzheimer's disease	0.000123	0.00057	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—F2—Alzheimer's disease	0.000121	0.000564	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—Alzheimer's disease	0.000121	0.000562	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARGC1A—Alzheimer's disease	0.00012	0.000559	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMOX1—Alzheimer's disease	0.00012	0.000557	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SST—Alzheimer's disease	0.000119	0.000554	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000119	0.000554	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GAB2—Alzheimer's disease	0.000119	0.000554	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLCB1—Alzheimer's disease	0.000119	0.000554	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CALM1—Alzheimer's disease	0.000119	0.000552	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000118	0.000549	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APP—Alzheimer's disease	0.000116	0.00054	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ESR1—Alzheimer's disease	0.000113	0.000524	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—F2—Alzheimer's disease	0.000112	0.000519	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—Alzheimer's disease	0.000111	0.000517	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGFR—Alzheimer's disease	0.000111	0.000517	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—Alzheimer's disease	0.000111	0.000516	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CREB1—Alzheimer's disease	0.00011	0.000514	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLCB1—Alzheimer's disease	0.00011	0.00051	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—LPL—Alzheimer's disease	0.00011	0.000509	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	0.000109	0.000508	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NOTCH1—Alzheimer's disease	0.000109	0.000506	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADAM10—Alzheimer's disease	0.000109	0.000505	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL2—Alzheimer's disease	0.000108	0.000502	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—Alzheimer's disease	0.000103	0.000478	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—S100B—Alzheimer's disease	0.000103	0.000477	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGFR—Alzheimer's disease	0.000102	0.000476	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—Alzheimer's disease	0.000102	0.000475	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000102	0.000474	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CREB1—Alzheimer's disease	0.000102	0.000473	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADAM10—Alzheimer's disease	9.99e-05	0.000465	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL2—Alzheimer's disease	9.95e-05	0.000462	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—Alzheimer's disease	9.86e-05	0.000458	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—Alzheimer's disease	9.78e-05	0.000454	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1R—Alzheimer's disease	9.45e-05	0.000439	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—S100B—Alzheimer's disease	9.45e-05	0.000439	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA4—Alzheimer's disease	9.3e-05	0.000432	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CALM1—Alzheimer's disease	9.21e-05	0.000428	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—Alzheimer's disease	9.18e-05	0.000427	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—Alzheimer's disease	9.14e-05	0.000425	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAV1—Alzheimer's disease	9.1e-05	0.000423	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	9.09e-05	0.000423	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LPL—Alzheimer's disease	9.06e-05	0.000421	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—Alzheimer's disease	9e-05	0.000418	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MEF2C—Alzheimer's disease	8.98e-05	0.000417	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCG—Alzheimer's disease	8.81e-05	0.00041	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	8.75e-05	0.000407	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1R—Alzheimer's disease	8.7e-05	0.000404	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGF—Alzheimer's disease	8.58e-05	0.000399	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—Alzheimer's disease	8.41e-05	0.000391	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—Alzheimer's disease	8.35e-05	0.000388	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LPL—Alzheimer's disease	8.34e-05	0.000388	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	8.29e-05	0.000385	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MEF2C—Alzheimer's disease	8.27e-05	0.000384	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR2A—Alzheimer's disease	8.17e-05	0.00038	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCG—Alzheimer's disease	8.11e-05	0.000377	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—Alzheimer's disease	8e-05	0.000372	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLD3—Alzheimer's disease	7.91e-05	0.000368	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	7.91e-05	0.000368	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGF—Alzheimer's disease	7.9e-05	0.000367	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—INS—Alzheimer's disease	7.84e-05	0.000365	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.82e-05	0.000363	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—Alzheimer's disease	7.72e-05	0.000359	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—Alzheimer's disease	7.69e-05	0.000357	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CALM1—Alzheimer's disease	7.62e-05	0.000354	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—Alzheimer's disease	7.6e-05	0.000353	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—Alzheimer's disease	7.6e-05	0.000353	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	7.58e-05	0.000352	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CAV1—Alzheimer's disease	7.53e-05	0.00035	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR2A—Alzheimer's disease	7.52e-05	0.00035	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.41e-05	0.000344	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	7.3e-05	0.000339	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—Alzheimer's disease	7.25e-05	0.000337	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2—Alzheimer's disease	7.17e-05	0.000333	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—Alzheimer's disease	7.1e-05	0.00033	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ND1—Alzheimer's disease	7.05e-05	0.000328	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CALM1—Alzheimer's disease	7.02e-05	0.000326	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOTCH1—Alzheimer's disease	7.01e-05	0.000326	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—Alzheimer's disease	6.99e-05	0.000325	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—Alzheimer's disease	6.99e-05	0.000325	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CAV1—Alzheimer's disease	6.93e-05	0.000322	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.89e-05	0.00032	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—Alzheimer's disease	6.88e-05	0.00032	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—Alzheimer's disease	6.68e-05	0.00031	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2—Alzheimer's disease	6.59e-05	0.000306	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GSK3B—Alzheimer's disease	6.58e-05	0.000306	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CREB1—Alzheimer's disease	6.53e-05	0.000303	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INS—Alzheimer's disease	6.49e-05	0.000302	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOTCH1—Alzheimer's disease	6.45e-05	0.0003	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—Alzheimer's disease	6.39e-05	0.000297	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.3e-05	0.000293	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—Alzheimer's disease	6.29e-05	0.000292	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—Alzheimer's disease	6.28e-05	0.000292	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GSK3B—Alzheimer's disease	6.06e-05	0.000281	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CREB1—Alzheimer's disease	6.01e-05	0.000279	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INS—Alzheimer's disease	5.97e-05	0.000278	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—Alzheimer's disease	5.88e-05	0.000273	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—Alzheimer's disease	5.78e-05	0.000269	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—Alzheimer's disease	5.69e-05	0.000265	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.43e-05	0.000252	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—Alzheimer's disease	5.24e-05	0.000243	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.95e-05	0.00023	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—Alzheimer's disease	4.88e-05	0.000227	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—Alzheimer's disease	4.83e-05	0.000225	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—Alzheimer's disease	4.8e-05	0.000223	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TPI1—Alzheimer's disease	4.54e-05	0.000211	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CHAT—Alzheimer's disease	4.54e-05	0.000211	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—Alzheimer's disease	4.49e-05	0.000209	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—Alzheimer's disease	4.45e-05	0.000207	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—Alzheimer's disease	4.44e-05	0.000206	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—Alzheimer's disease	4.43e-05	0.000206	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—Alzheimer's disease	4.42e-05	0.000205	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MAOB—Alzheimer's disease	4.36e-05	0.000202	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	4.19e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.15e-05	0.000193	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.11e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—Alzheimer's disease	4.1e-05	0.000191	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—Alzheimer's disease	4.09e-05	0.00019	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—Alzheimer's disease	4.08e-05	0.000189	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—Alzheimer's disease	4.07e-05	0.000189	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—A2M—Alzheimer's disease	4.05e-05	0.000188	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—Alzheimer's disease	3.77e-05	0.000175	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—Alzheimer's disease	3.76e-05	0.000175	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.61e-05	0.000168	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACHE—Alzheimer's disease	3.52e-05	0.000164	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	3.48e-05	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—Alzheimer's disease	3.46e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.3e-05	0.000153	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.3e-05	0.000153	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.24e-05	0.00015	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—Alzheimer's disease	3.16e-05	0.000147	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—Alzheimer's disease	3.1e-05	0.000144	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.07e-05	0.000143	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.9e-05	0.000135	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—Alzheimer's disease	2.85e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.84e-05	0.000132	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—Alzheimer's disease	2.84e-05	0.000132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.81e-05	0.00013	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—Alzheimer's disease	2.62e-05	0.000122	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—Alzheimer's disease	2.61e-05	0.000121	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.42e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.41e-05	0.000112	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—Alzheimer's disease	2.41e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.2e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.98e-05	9.22e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.85e-05	8.61e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.85e-05	8.58e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.83e-05	8.5e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.61e-05	7.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—INS—Alzheimer's disease	1.58e-05	7.33e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.38e-05	6.43e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.26e-05	5.88e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.36e-06	2.95e-05	CbGpPWpGaD
